SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Ulysses S. Grant — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientUlysses S. Grant
Date of birth1822-04-27
IdentifiersMRN HR-NI002-SYN-TD; SSN (made up) 000-02-9416
Document date1884-08-04
AuthorCorinne Batiste, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Pre-treatment primary care review after staging. [S]

History of Present Illness

Mr. Grant returns after staging. The final pathology confirmed p16-negative squamous cell carcinoma of the right tonsillar pillar, and last week's PET/CT showed no distant spread. The head and neck oncology team has recommended chemoradiation, to start in about ten days. The cold he had last week has cleared, apart from a light cough in the mornings. His throat pain is 4 of 10, down from 6 while he was coughing. He weighs 75.5 kg, 2.5 kg below his weight at intake. He saw the dietitian last week and takes soft, calorie-dense foods with two supplement drinks a day. He has smoked no cigars for three weeks and takes varenicline 1 mg twice daily after meals without nausea or changes in mood or sleep. He worries about money and about finishing his memoir during treatment, but still enjoys his writing and his visitors. He has not yet seen a dentist. [S]

ElementDetail
Stagingp16-negative squamous cell carcinoma; PET/CT shows no distant spread
Treatment planChemoradiation by the head and neck oncology team, starting in about ten days
Pain4 of 10, down from 6 during last week's cold
Weight and nutrition75.5 kg, down 2.5 kg from intake; dietitian seen; two supplement drinks a day
TobaccoNo cigars for three weeks; varenicline 1 mg twice daily tolerated
MoodWorried about money and his memoir; still enjoys his writing

Review of Systems

SystemResultFinding
ConstitutionalPositiveWeight down 2.5 kg since intake; no fever
Ears, nose, mouth, and throatPositiveRight-sided throat pain, 4 of 10, worse with swallowing; nasal congestion resolved
RespiratoryPositiveLight morning cough after last week's cold; no sputum, hemoptysis, or breathlessness
GastrointestinalNegativeNo nausea or vomiting
PsychiatricPositiveWorry about finances and his writing; interest and enjoyment preserved; PHQ-2 score 2

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Varenicline 0.5 mg oral tablet, one tablet daily for three days, then one tablet twice dailyOne tablet by mouth daily for three days, then twice dailyOral route1884-07-07 to 1884-07-21completedS
Varenicline 1 mg oral tablet, one tablet twice dailyOne tablet by mouth twice daily after mealsOral route1884-07-21activeS
Acetaminophen 160 mg/5 mL oral solution, 20 mL (640 mg) every 6 hours as needed for throat pain20 mL by mouth every 6 hours as needed for pain; no more than 3,000 mg a dayOral route1884-07-07activeS
Lidocaine viscous 2% solution, 15 mL swish and spit up to every 3 hours as needed for throat painSwish 15 mL and spit up to every 3 hours as needed, no more than 8 doses a day; do not eat or drink for 60 minutes after useTopical route1884-07-07activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1884-08-04Body height173cmS
1884-08-04Body weight75.5kgS
1884-08-04Body mass index (BMI) [Ratio]25.2kg/m2S
1884-08-04Systolic blood pressure128mm[Hg]S
1884-08-04Diastolic blood pressure78mm[Hg]S
1884-08-04Heart rate74/minS
1884-08-04Respiratory rate16/minS
1884-08-04Body temperature36.8CelS
1884-08-04Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1884-08-04Hemoglobin [Mass/volume] in Blood13.8g/dL13.2-16.6 g/dLNormalS
1884-08-04Leukocytes [#/volume] in Blood by Automated count7.910*3/uL4-11 10*3/uLNormalS
1884-08-04Platelets [#/volume] in Blood by Automated count25510*3/uL150-400 10*3/uLNormalS
1884-08-04Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
1884-08-04Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
1884-08-04Creatinine [Mass/volume] in Serum or Plasma0.95mg/dL0.74-1.35 mg/dLNormalS
1884-08-04Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1879)/1.73 sq M90mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1884-08-04Glucose [Mass/volume] in Serum or Plasma90mg/dL70-99 mg/dLNormalS
1884-08-04Albumin [Mass/volume] in Serum or Plasma3.6g/dL3.5-5 g/dLNormalS
1884-08-04Pain severity - 0-10 verbal numeric rating [Score] - Reported4{score}S
1884-08-04Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]2{score}S

Physical Exam

Vital signs recorded on 1884-08-04; see the Vital Signs section. [S]

SystemFinding
GeneralAlert; lost some weight but well-appearing
OropharynxUlcerated lesion of the right tonsillar pillar; biopsy site healed
Teeth and gumsSeveral restored teeth and gum recession; no obvious abscess
NeckFirm right level II node, unchanged; no new nodes
LungsClear

Problems

ProblemClinical statusVerificationCodeProvenance
Squamous cell carcinoma of the right tonsillar pillar, p16-negative, suspected at presentation and confirmed by biopsy at the otolaryngology visit; linked to the documented 1885 diagnosisactiveconfirmed C09.1S — Synthetic diagnosis in the modern episode; the 1884-1885 findings remain D.
Nicotine dependence, cigars, about ten a day for more than forty yearsactiveconfirmed F17.290S — Synthetic modern diagnosis linked to documented heavy cigar smoking.
Painful swallowing with oropharyngeal dysphagia from the tonsillar tumoractiveconfirmed R13.12S — Synthetic symptom diagnosis echoing the documented painful swallowing.
Unintended weight loss from painful swallowing, about 2 kg before presentationactiveconfirmed R63.4S — Synthetic finding from the measured weights.
Acute viral bronchitis after a head cold during the cancer workup, resolved without antibioticsresolvedconfirmed J20.9S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryCBC, basic metabolic panel, and albuminBefore and after treatmentCompleted todayHemoglobin 13.8, white count 7.9, platelets 255, sodium 138, potassium 4.4, creatinine 0.95, eGFR 90, glucose 90, all normal; albumin 3.6, down from 3.9
LaboratoryFinal pathology with p16At diagnosisUp to dateSquamous cell carcinoma, p16-negative
ImagingPET/CT for stagingOnce carcinoma is confirmedUp to dateDone last week: no distant spread
LaboratoryTSHBaseline before neck radiation, then every 6 to 12 months after itUp to dateBaseline 1.8 mIU/L at intake
ReferralMultidisciplinary head and neck oncology teamAfter tissue diagnosisUp to dateSeen; chemoradiation recommended, starting in about ten days
ReferralDental evaluation before radiationBefore radiation to the neckReferredBooked for this week, before radiation planning
ReferralSpeech-language pathology swallowing baselineBefore treatmentReferredReferred today for a baseline assessment and preventive swallowing exercises
ReferralDietitian assessmentBefore treatmentUp to dateSeen last week; soft, calorie-dense diet with two supplement drinks a day
ExaminationWeightEvery visitCompleted today75.5 kg, 3.2 percent below baseline
SurveyThroat pain score (0-10)Every visitCompleted today4 of 10
SurveyDepression screen (PHQ-2)Every primary care visit after the diagnosisCompleted todayScore 2
Self-managementTobacco use status and cessation counselingEvery visitCompleted todayNo cigars for three weeks; relapse-prevention counseling given
Medication safetyVarenicline tolerance: nausea, sleep, mood, and behaviorEach visit during treatmentCompleted todayNo nausea, mood, sleep, or behavior change on 1 mg twice daily
Medication safetyPneumococcal vaccination before cancer treatmentOnceCompleted todayPCV20 given today

Goal progress:

Immunizations given today: Pneumococcal conjugate vaccine PCV20 [S]

Guideline basis: NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2025 (2025); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); CMID: Clinical Monitoring Intelligence Database, depression and hypothyroidism monographs (2026)

Follow-up: Chemoradiation with the head and neck oncology team, starting in about ten days; that team follows his weight, pain, and blood counts weekly during treatment. Primary care visit about three weeks after treatment ends. Next scheduled visit 1884-10-22: primary care visit three weeks after completing chemoradiation directed by the head and neck oncology team. [S]